Evidence map›Paper›PMID 33613752›Full record

ArticleJournal of Cancer2021

Identifying Potential Markers for Monitoring Progression to Ovarian Cancer Using Plasma Label-free Proteomics.

Wenjie Wang, Hongyu Xie, Bairong Xia, Liuchao Zhang, Yan Hou, Kang Li

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wenjie WangDepartment of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150086, China.
Hongyu XieDepartment of Gynecology Oncology, Harbin Medical University Cancer Hospital, Harbin 150000, China.
Bairong XiaDepartment of Gynecology Oncology, Harbin Medical University Cancer Hospital, Harbin 150000, China.
Liuchao ZhangDepartment of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150086, China.
Yan HouDepartment of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150086, China.
Kang LiDepartment of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150086, China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CRPdiagnosisovarian cancerprogressionproteomics

Identifiers

PMID33613752
PMCPMC7890305
OpenAlexW3127501022

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.